Lisa helps clients develop clear, concise content that stands out in the life sciences market. She writes about complex topics, including strategies for oncology drug development, the use of expedited regulatory mechanisms, and the challenges of developing advanced technologies such as gene and CAR T-cell therapies.
Lisa interviews subject matter experts to develop technical articles for peer-reviewed journals, thought leadership essays for trade journals and business publications, and self-published white papers, brochures, and blog posts.
Before joining Rhetoriq, Lisa was a senior manager at Deloitte, a clinical database product designer at Recombinant Capital, an editor at BioWorld Today, and a marketing manager at Xoma Corp., now a biotech royalty aggregator. She has an MA from Columbia University’s School of International and Public Affairs and a BA in history from the University of California at Davis.